REFERENCES
- TIF. Guidelines for Clinical Management of Thalassaemia. (Book). Revised 2nd ed. Capellini, N, Cohen, A, Eleftheriou, A, Piga, A, Porter, JB, Taher, A, eds. Thalassaemia International Federation, Nicosia, Cyprus; 2008.
- Hogman CF. Preparation and preservation of red cells. Vox Sang. 1998;74(Suppl.2):177–187.
- Sprogoe-Jakobsen U, Saetre AM, Georgsen J. Preparation of white cell-reduced red cells by filtration: Comparison of a beside filter and two blood bank filter systems. Transfusion. 1995;35:421–426.
- Buchholz DH, AuBuchon JP, Snyder EL, et al. Removal of yersinia enterocolitica from AS-1 red cells. Transfusion. 1992;32:667–672.
- Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang. 1990;58:50–55.
- Rebulla P, Modell B. Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme. Lancet. 1991;337:277–280.
- Cunningham MJ, Macklin EA, Singer ST, et al. Red blood cell allo- and autoantibodies in the thalassemia clinical research network. Blood 2005;106: Abstract 1890.
- TIF. In A. Elefteriou ( ed.) Blood Safety Kit: Thalassaemia International Federation; 1999.
- Pelletier JP, Transue S, Snyder EL. Pathogen inactivation techniques. Best Pract Res Clin Haematol. 2006;19:205–242.
- Solheim BG. Pathogen reduction of blood components. Transfus Apher Sci. 2008;39:75–82.
- Lu SJ, Feng Q, Park JS, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112:4475–4484.
- Cazzola M, De Stefano P, Ponchio L, et al. Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol. 1995;89:473–478.
- Cazzola M, Borgna-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De Stefano P. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion. 1997;37:135–140.
- Gabutti V, Piga A, Nicola P, et al. Haemoglobin levels and blood requirement in thalassaemia. Arch Dis Child. 1982;57:156–157.
- Propper RD, Button LN, Nathan DG. New approaches to the transfusion management of thalassemia. Blood. 1980;55:55–60.
- Brunengo MA, Girot R. Transfusion requirements and mean annual hemoglobin level in thalassemia major. Nouv Rev Fr Hematol. 1986;28:309–313.
- Porter JB. Practical management of iron overload. Br J Haematol. 2001;115:239–252.
- Cohen AR, Glimm E, Porter JB. Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood. 2008;111:583–587.
- Graziano JH, Piomelli S, Hilgartner M, et al. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. J Pediatr. 1981;99:695–699.
- Cohen AR, Glimm E, Porter JB. Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood. 2008;111:583–587.
- O'Brien RT, Pearson HA, Spencer RP. Transfusion-induced decrease in spleen size in thalassemia major: Documentation by radioisotopic scan. J Pediatr. 1972;81:105–107.
- Modell B. Total management of thalassaemia major. Arch Dis Child. 1977;52:485–500.